The pharmaceutical companies of India and China have been experiencing such very fast expansion in the past few years that they are widely recognized as two of the world’s most active and promising markets of Pharmaceutical API and Intermediate manufacturing and sourcing options. subsequently, they have attracted many drug companies around the world. The strengths and weaknesses of each country and their advantages and disadvantages to certain sourcing/outsourcing projects have become the key make a distinction.
- This year CPhI China represents a great opportunity to do business for Indian Pharma companies also. This platform offers Indian companies a invaluable opportunity to become an industry expert and also to learn from their Chinese counterparts. The exhibition includes on-site conferences, seminars, forums, discovery and innovation tours, summits and showcases to look for and networking and creating new global customers for Indian Pharma companies and also a new sourcing opportunities to learn the strengths and positivity of the Chinese Pharma API sourcing and manufacturing companies.
- “CPhI China is the most comprehensive pure pharma focused event for domestic and international pharmaceutical companies in Asia. (Taken from CPhI website)
“Over 35,000 pharma professionals from more than 120 countries around the world gather for a host of events that cover all aspects of the pharmaceutical supply chain. CPhI China gives you with the opportunities to meet, network, do business, share ideas and shape the future of the Indian pharmaceutical industry”.
Created By: Vinita Bhandari www.getdigitalpartner.com
